Levex i.v. 250

Levex i.v. 250 is a medicine authorised by Swissmedic under authorisation number 61816. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 May 2011 and the authorisation is valid without a time limit. ATC code J01MA12 places the medicine in the group Antibacterials for systemic use.

Dispensing category A
Authorisation number 61816
ATC J01MA12
Synthetic medicines

Authorisation data
Authorisation number	61816
Name	Levex i.v. 250
Full name	Levex i.v. 250, soluzione per perfusione
Authorisation holder	Lagap SA
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	J01MA12
First authorisation	04 May 2011
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Levex i.v. 250, soluzione per perfusione	A	04 May 2011
2	Levex i.v. 500, soluzione per perfusione	A	04 May 2011

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	10 x 50	ml	J01MA12	08.01.8.	A
2	24 x 50	ml	J01MA12	08.01.8.	A
3	10 x 100	ml	J01MA12	08.01.8.	A
4	24 x 100	ml	J01MA12	08.01.8.	A

Scroll the table sideways

Medicines in the same ATC group

Levofloxacin Fresenius i.v. 250 mg/50 mlAuthorisation number 62207 · Fresenius Kabi (Schweiz) AG · ATC J01MA12A Levofloxacin Sandoz 250Authorisation number 59085 · Sandoz Pharmaceuticals AG · ATC J01MA12A Levofloxacin-Mepha Teva 250 mgAuthorisation number 60245 · Mepha Pharma AG · ATC J01MA12A QuinsairAuthorisation number 66555 · Chiesi SA · ATC J01MA12A Tavanic 250 mgAuthorisation number 54365 · Sanofi-Aventis (Suisse) SA · ATC J01MA12A Tavanic i.v. 500Authorisation number 54366 · Sanofi-Aventis (Suisse) SA · ATC J01MA12A

Other medicines from this authorisation holder

Amoxidin Plus 1 gAuthorisation number 68102 · ATC J01CR02A Amoxidin Plus 625 mgAuthorisation number 68103 · ATC J01CR02A Azithrolag 250 mgAuthorisation number 70191 · ATC J01FA10A Bedranol 10 mgAuthorisation number 66719 · ATC C07AA05B Ceftriaxon Lagap 500 mg i.v.Authorisation number 68535 · ATC J01DD04A Dapalag 5 mgAuthorisation number 70321 · ATC A10BK01B DecalcitAuthorisation number 12337D DecalcitAuthorisation number 19035D

Frequently asked questions

Is Levex i.v. 250 authorised in Switzerland?

Yes. Levex i.v. 250 is authorised by Swissmedic under authorisation number 61816, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Levex i.v. 250 have?

Levex i.v. 250 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Levex i.v. 250?

The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.